Written questions by Whittingdale.

When he expects the Lampard Inquiry to report; and what steps he is taking to support the Inquiry.

Although the Department sponsors the Lampard Inquiry, the inquiry is independent of the Government. Baroness Lampard has committed to publish the final report as soon as possible and the inquiry will publish its intended timescales in due course. The next hearings are due to commence on 13 October 2025, with further hearings scheduled throughout 2026. The Government is committed to ensuring that lessons are learned from the Lampard Inquiry to improve patient safety. The Department is a core participant to the inquiry and will give evidence. We are confident that the inquiry will play an important role in identifying wider learning for the health system and will contribute to improvements in patient safety. The inquiry continues to be funded by the Department.

What proportion of cancer patients receive treatment within 62 days in (a) England and (b) Maldon constituency.

The latest data for England shows that 67.1% of people started treatment within 62 days of referral. Data on the 62 day referral to treatment cancer waiting time standard is available by integrated care board (ICB) area, but not by constituency. The Maldon constituency falls within the Mid and South Essex ICB, and therefore the following table shows the proportion of cancer patients who receive treatment within 62 days in June 2024 and June 2025, and the change over this 12 month period, for both England and the Mid and South Essex ICB:Cancer62 day standard (85% standard)June 2025National67.1%ICB43.5%June 2024National67.9%ICB47.8%12-month changeNational-0.8%ICB-4.3%

What steps he is taking to publicise the need for vaccination against (a) influenza and (b) covid-19.

This year, we are carrying out a major campaign aimed at eligible people, encouraging them to take up their vaccinations, supported by millions of targeted emails, texts and letters sent nationally. The winter vaccination national booking service is opening earlier than ever for advance bookings, supported by a press and social media launch.The Department works closely with partners at the UK Health Security Agency (UKHSA) and NHS England to produce a variety of influenza and COVID-19 communication tools and materials including translation of information and guidance materials into over 30 languages; in accessible formats including braille, audio, large print, Easy Read and British Sign Language; dedicated products for target population groups for individual vaccine programmes; and focused work with relevant third sector organisations ahead of major campaigns.For the 2025-26 flu season, we are encouraging those most at risk of serious illness to get vaccinated. Targeted communications to pregnant women and the parents of eligible children started this month. The campaign for other eligible groups will run from October 2025 and will consist of TV, radio advertising, digital advertising, both social and display, supported by search and partnership activity.Additionally, NHS England has developed an enhanced campaign aimed at improving flu uptake among frontline health and social care workers, using multiple ways to reach staff including workplace communications, partnerships with unions and professional bodies, and materials tailored for different healthcare roles.

Whether chemostat can be prescribed by the NHS for the treatment of patients with ocular melanoma.

Chemosaturation therapy, often referred to as chemostat, is used to treat cancer that has spread to the liver arising from ocular melanoma. It is not used to treat ocular melanoma alone.The National Institute for Health and Care Excellence published guidance in 2021, through its interventional procedures programme, that recommends that chemosaturation can be used for patients with secondary liver metastases resulting from a primary ocular melanoma.NHS England considered the case for the commissioning of chemosaturation for liver metastases from ocular melanoma in 2016. At that time, NHS England concluded that there was insufficient clinical evidence to support the proposal to make the treatment available for patients with ocular melanoma in the National Health Service.In December 2024, NHS England announced the roll out of a new treatment across England called tebentafusp, which is now available for patients with uveal melanoma, which is the most common form of ocular melanoma.

When he plans to publish the report of the CQC inspection of maternity services in Mid and South Essex carried out in March 2024.

The Care Quality Commission (CQC) is working to publish its report following its inspection of maternity services in Mid and South Essex at the earliest opportunity. Publication of the report, following the Care Quality Commission’s inspection of maternit...

If he will publish details of the Section 31 notice issued to Mid and South Essex Hospitals relating to maternity services at Broomfield Hospital.

The Care Quality Commission (CQC) is working to publish its report following its inspection of maternity services in Mid and South Essex at the earliest opportunity. Publication of the report, following the Care Quality Commission’s inspection of maternit...

What the the average number of patients per GP is in (a) the Maldon District, (b) Mid and South Essex and (c) England.

In August 2024, the median number of patients per full-time equivalent (FTE) fully qualified general practitioner was:3,030 in the Maldon District;2,759 in the NHS Mid and South Essex Integrated Care Board (ICB); and2,300 in England.In the same period, th...